Showing results (231-240 of 343) with videos related to
Sort By:
Pageof 35
British Journal of Haematology|July 15, 2011
GIMEMA AIDA 0493 amended protocol for elderly patients with acute promyelocytic leukaemia. Long-term results and prognostic factorsRoberto Latagliata, Massimo Breccia, Paola Fazi, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 15, 2009
Daunorubicin versus mitoxantrone versus idarubicin as induction and consolidation chemotherapy for adults with acute myeloid leukemia: the EORTC and GIMEMA Groups Study AML-10Franco Mandelli, Marco Vignetti, Stefan Suciu, et al.Lancet (London, England)|December 15, 2010
Bortezomib with thalidomide plus dexamethasone compared with thalidomide plus dexamethasone as induction therapy before, and consolidation therapy after, double autologous stem-cell transplantation in newly diagnosed multiple myeloma: a randomised phase 3 studyMichele Cavo, Paola Tacchetti, Francesca Patriarca, et al.Plos One|June 26, 2015
Flow Cytometric Immunobead Assay for Detection of BCR-ABL1 Fusion Proteins in Chronic Myleoid Leukemia: Comparison with FISH and PCR TechniquesAnna Grazia Recchia, Nadia Caruso, Sabrina Bossio, et al.Scientific Reports|May 4, 2022
In-vitro NET-osis induced by COVID-19 sera is associated to severe clinical course in not vaccinated patients and immune-dysregulation in breakthrough infectionAlessandra Romano, Nunziatina Laura Parrinello, Martina Barchitta, et al.European Journal of Haematology|November 21, 2008
Considerations in the treatment of multiple myeloma: a consensus statement from Italian expertsFrancesca Patriarca, Maria T Petrucci, Sara Bringhen, et al.Plos One|September 8, 2011
Relevance of stereotyped B-cell receptors in the context of the molecular, cytogenetic and clinical features of chronic lymphocytic leukemiaFrancesco Maura, Giovanna Cutrona, Sonia Fabris, et al.Annals of Hematology|November 7, 2009
Amyloid in bone marrow smears of patients affected by multiple myelomaFara Petruzziello, Pio Zeppa, Lucio Catalano, et al.Journal of Hematology & Oncology|November 29, 2013
Detection of TP53 dysfunction in chronic lymphocytic leukemia by an in vitro functional assay based on TP53 activation by the non-genotoxic drug Nutlin-3: a proposal for clinical applicationFederico Pozzo, Michele Dal Bo, Nadia Peragine, et al.Frontiers in Oncology|August 29, 2019
BCR-ABL1 Doubling-Times and Halving-Times May Predict CML Response to Tyrosine Kinase InhibitorsMaria Stella Pennisi, Stefania Stella, Silvia Rita Vitale, et al.Pageof 35